Based on extensive preclinical studies, MRANK-106 is differentiated from other WEE1 inhibitors in development by its: Dual targeting of WEE1 and YES1 kinases, providing synergistic anti-tumor effects ...
Heron Therapeutics' market cap has risen to ~$360 million, trading at ~$2.38, since my last Hold rating in November 2024.
Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...
A paper from 2018 in the American Journal of Cancer Research piqued his interest when he read that a little-known molecule ...
The college’s Visualizing Science competition finalists include the winning image of a Logistic Map’s Chaotic Portion by an ...
Reported promising safety and preliminary efficacy data for REC-617, an oral CDK7 inhibitor, and met primary endpoints and demonstrated ...
Oxford Nanopore Technologies plc ( OTCPK:ONTTF) Q4 2024 Results Conference Call March 4, 2025 4:30 AM ET Gordon Sanghera - Chief Executive Officer Nick Keher - Chief Financial Officer ...
Saturation A molecule is saturated if every bond between carbon atoms is a single edge (think of a graph with only one edge between nodes). In our naming, if no edge in the parent chain is marked as ...
28d
AZoNano on MSNEco-Friendly Graphene Ink Revolutionizes 3D PrintingContinuous generation of graphene nanosheets in water is made possible by a specially engineered process known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results